MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ejhf.3168

Медицинская библиотека · European journal of heart failure · 2024

Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.

Setti Martina, Merlo Marco, Gigli Marta, Munaretto Laura, Paldino Alessia, Stolfo Davide, Pio Loco Carola, Medo Kristen, Gregorio Caterina, De Luca Antonio, Graw Sharon, Castrichini Matteo, Cannatà Antonio, Ribichini Flavio Luciano, Dal Ferro Matteo, Taylor Matthew, Sinagra Gianfranco, Mestroni Luisa

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

AIMS: Dilated cardiomyopathy (DCM) with arrhythmic phenotype combines phenotypical aspects of DCM and predisposition to ventricular arrhythmias, typical of arrhythmogenic cardiomyopathy. The definition of DCM with arrhythmic phenotype is not universally accepted, leading to uncertainty in the identification of high-risk patients. This study aimed to assess the prognostic impact of arrhythmic phenotype in risk stratification and the correlation of arrhythmic markers with high-risk arrhythmogenic gene variants in DCM patients.

METHODS AND

RESULTS

In this multicentre study, DCM patients with available genetic testing were analysed. The following arrhythmic markers, present at baseline or within 1 year of enrolment, were tested: unexplained syncope, rapid non-sustained ventricular tachycardia (NSVT), ≥1000 premature ventricular contractions/24 h or ≥50 ventricular couplets/24 h. LMNA, FLNC, RBM20, and desmosomal pathogenic or likely pathogenic gene variants were considered high-risk arrhythmogenic genes. The study endpoint was a composite of sudden cardiac death and major ventricular arrhythmias (SCD/MVA). We studied 742 DCM patients (45 ± 14 years, 34% female, 410 [55%] with left ventricular ejection fraction [LVEF] <35%). During a median follow-up of 6 years (interquartile range 1.6-12.1), unexplained syncope and NSVT were the only arrhythmic markers associated with SCD/MVA, and the combination of the two markers carried a significant additive risk of SCD/MVA, incremental to LVEF and New York Heart Association class. The probability of identifying an arrhythmogenic genotype rose from 8% to 30% if both early syncope and NSVT were present.

CONCLUSION

In DCM patients, the combination of early detected NSVT and unexplained syncope increases the risk of life-threatening arrhythmic outcomes and can aid the identification of carriers of malignant arrhythmogenic genotypes.

Для цитирования: Setti Martina, Merlo Marco, Gigli Marta, Munaretto Laura, Paldino Alessia, Stolfo Davide, Pio Loco Carola, Medo Kristen, Gregorio Caterina, De Luca Antonio, Graw Sharon, Castrichini Matteo, Cannatà Antonio, Ribichini Flavio Luciano, Dal Ferro Matteo, Taylor Matthew, Sinagra Gianfranco, Mestroni Luisa. Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.. European journal of heart failure. 2024. DOI: 10.1002/ejhf.3168.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.